VCIM
TARA icon

Velan Capital Investment Management’s Protara Therapeutics TARA Stock Holding History

Velan Capital Investment Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Buy
2,844,652
+10,000
+0.4% +$47.6K 6.62% 5
2026
Q1 		$14.8M Hold
2,834,652
– – 9.25% 2
2025
Q4 		$15.1M Buy
2,834,652
+695,652
+33% +$3.87M 8.76% 3
2025
Q3 		$9.3M Hold
2,139,000
– – 8.74% 3
2025
Q2 		$6.48M Buy
2,139,000
+471,200
+28% +$1.63M 6.4% 4
2025
Q1 		$7.1M Buy
1,667,800
+88,800
+6% +$397K 7.31% 4
2024
Q4 		$8.34M Buy
1,579,000
+1,005,000
+175% +$3.25M 7.19% 5
2024
Q3 		$1.05M Buy
574,000
+94,000
+20% +$193K 0.98% 14
2024
Q2 		$998K Buy
+480,000
New +$1.4M 0.57% 14

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Velan Capital Investment Management's TARA Position: Q2 2026 in Review

Velan Capital Investment Management increased its Protara Therapeutics (TARA) stake by 0.35% in Q2 2026, buying an estimated $47.6K and bringing the position to 2,844,652 shares worth $10.9M. The position accounts for 6.62% of the portfolio, ranked #5.

Velan Capital Investment Management first reported a position in TARA in Q2 2024 and has held it in 9 quarters since. The position peaked at $15.1M in Q4 2025. 119 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Velan Capital Investment Management held 2,844,652 shares of Protara Therapeutics worth $10.9M as of Q2 2026.
  • Velan Capital Investment Management bought 10,000 Protara Therapeutics shares in Q2 2026, an estimated $47.6K.
  • Protara Therapeutics made up 6.62% of Velan Capital Investment Management's portfolio in Q2 2026, its #5 holding.
  • Velan Capital Investment Management first reported a position in Protara Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Velan Capital Investment Management's Protara Therapeutics position peaked at $15.1M in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Velan Capital Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.